GABBROVET 140 MG/ML SOLUTION FOR USE IN DRINKING WATER, MILK OR MILK REPLACER FOR PRE-RUMINANT CATTLE AND PIGS
GABBROVET 140 MG/ML SOLUTION FOR USE IN DRINKING WATER, MILK OR MILK REPLACER FOR PRE-RUMINANT CATTLE AND PIGS
Not authorised
- Paromomycin sulfate
Product identification
Medicine name:
GABBROVET 140 MG/ML SOLUTION FOR USE IN DRINKING WATER, MILK OR MILK REPLACER FOR PRE-RUMINANT CATTLE AND PIGS
Gabbrovet 140 mg/ml opløsning til anvendelse i drikkevand/mælk
Active substance:
- Paromomycin sulfate
Target species:
-
Cattle
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Paromomycin sulfate200.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for use in drinking water
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Meat and offal20day
-
- Pig
-
Meat and offal3day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Denmark
Package description:
- Box of 1 vial of 250 mL
- Box of 1 vial of 500 mL
- Box of 1 vial of 1000 mL
- Vial of 125 mL
- Vial of 250 mL
- Vial of 500 mL
- Vial of 1000 mL
- Box of 1 vial of 125 mL
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 59069
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0317/001/DC
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 4/07/2022
How useful was this page?: